24-Nor-5beta-chol-22-ene-3alpha,7alpha,12alpha-triol

Metabolite details

Identifier

VLJOAPYLXOBUNB-ZTSBSJDLSA-N

InChI Key

VLJOAPYLXOBUNB-ZTSBSJDLSA-N

IUPAC name

(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-17-[(2R)-but-3-en-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

Preferred name

24-Nor-5beta-chol-22-ene-3alpha,7alpha,12alpha-triol

INN name

—

Synonym

—

ChEBI

CHEBI:185653

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium

Observed in differential profiles

• Control_vs_nsPEF_7_day
• G1_PBS_vs_G2_DSS
• Normal_vs_Neural_Tube_Defect
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d
• wild_type_vs_patA_deletion